Wearable Devices for Ambulatory Cardiac Monitoring

Sana, Furrukh; Isselbacher, Eric M.; Singh, Jagmeet P.; Heist, E. Kevin; Pathik, B.; Armoundas, Antonis A.

doi:10.1016/j.jacc.2020.01.046

Cited by 236 publications

(171 citation statements)

References 47 publications

Supporting

Mentioning

168

Contrasting

Unclassified

Order By: Relevance

“…As an example, electrophysiologists have been converting most clinical visits to remote monitoring (phone, video calls for visits, review of data from digital wearables, etc.) [ 9 , 10 ], as well as cardiac implantable electronic device checks, whenever feasible [ 11 ], as suggested as class I recommendation [ 12 ]. Where possible, nonurgent procedures should be postponed or, in the case of need, coordinated on the same day of visit to minimize multiple exposures, whilst postprocedural follow-up should be performed remotely.…”

Section: The Importance Of Telemedicine In a Pandemicmentioning

confidence: 99%

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

Galiero

Pafundi

Nevola

et al. 2020

Journal of Diabetes Research

136

101

View full text Add to dashboard Cite

Recently, telemedicine has become remarkably important, due to increased deployment and development of digital technologies. National and international guidelines should consider its inclusion in their updates. During the COVID-19 pandemic, mandatory social distancing and the lack of effective treatments has made telemedicine the safest interactive system between patients, both infected and uninfected, and clinicians. A few potential evidence-based scenarios for the application of telemedicine have been hypothesized. In particular, its use in diabetes and complication monitoring has been remarkably increasing, due to the high risk of poor prognosis. New evidence and technological improvements in telemedicine application in diabetic retinopathy (DR) have demonstrated efficacy and usefulness in screening. Moreover, despite an initial increase for devices and training costs, teleophthalmology demonstrated a good cost-to-efficacy ratio; however, no national screening program has yet focused on DR prevention and diagnosis. Lack of data during the COVID-19 pandemic strongly limits the possibility of tracing the real management of the disease, which is only conceivable from past evidence in normal conditions. The pandemic further stressed the importance of remote monitoring. However, the deployment of device and digital application used to increase screening of individuals and monitor progression of retinal disease needs to be easily accessible to general practitioners.

show abstract

Section: The Importance Of Telemedicine In a Pandemicmentioning

confidence: 99%

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

Galiero

Pafundi

Nevola

et al. 2020

Journal of Diabetes Research

136

101

View full text Add to dashboard Cite

show abstract

“…Today it is possible to remotely monitor cardiac rhythm and vital signs continuously on the hospital wards, where close nursing observation is not always possible. [32][33][34] Given the importance of treating diabetes and uncontrolled hyperglycemia in every unit of the hospital, and the improvements in performance of currentgeneration CGM systems, we say why not continuously measure glucose in the hospital as well? The appropriate implementation of this technology may significantly decrease the burden of glucose monitoring for patients and providers.…”

Section: Discussionmentioning

confidence: 99%

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic

Galindo

Aleppo

Klonoff

et al. 2020

J Diabetes Sci Technol

112

View full text Add to dashboard Cite

Continuous glucose monitoring (CGM) has become a widely used tool in the ambulatory setting for monitoring glucose levels, as well as detecting uncontrolled hyperglycemia, hypoglycemia, and glycemic variability. The accuracy of some CGM systems has recently improved to the point of manufacture with factory calibration and Food and Drug Administration clearance for nonadjunctive use to dose insulin. In this commentary, we analyze the answers to six questions about what is needed to bring CGM into the hospital as a reliable, safe, and effective tool. The evidence to date indicates that CGM offers promise as an effective tool for monitoring hospitalized patients. During the current coronavirus disease 2019 crisis, we hope to provide guidance to healthcare professionals, who are seeking to reduce exposure to SARS-Cov-2, as well as preserve invaluable personal protective equipment. In this commentary, we address who, what, where, when, why, and how CGM can be adopted for inpatient use.

show abstract

“…Many of these technologies are also being explored for various scenarios in cardiology (44)(45)(46)(47)(48)(49)(50)(51), and have great clinical utility for cardio-oncology and COVID-19. Remote monitoring from wearable biosensors and mHealth is being investigated to improve outcomes in heart rhythm and heart failure and other cardiovascular conditions (44,(46)(47)(48)(49)(50), and may have utility for COVID-19 (19,(52)(53)(54)(55)(56)(57)(58) and Cardio-Oncology (59)(60)(61). Voice apps and voice analysis have shown promise in cardiology for heart failure, ischemic heart disease, pulmonary hypertension, and other forms of cardiovascular disease (45,(62)(63)(64), as well as cardio-oncology (65), and have been considered for COVID-19.…”

Section: Innovation Beyond the Pandemic Artificial Intelligencementioning

confidence: 99%

“…All of these components can be useful in both the COVID-19 pandemic and the practice of Cardio-Oncology. Many of these technologies are also being explored for various scenarios in cardiology ( 44 – 51 ), and have great clinical utility for cardio-oncology and COVID-19. Remote monitoring from wearable biosensors and mHealth is being investigated to improve outcomes in heart rhythm and heart failure and other cardiovascular conditions ( 44 , 46 – 50 ), and may have utility for COVID-19 ( 19 , 52 – 58 ) and Cardio-Oncology ( 59 – 61 ).…”

Section: Innovation Beyond the Pandemicmentioning

confidence: 99%

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World

Brown

Rhee

Guha

et al. 2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Wearable Devices for Ambulatory Cardiac Monitoring

Cited by 236 publications

References 47 publications

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy

Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World

Contact Info

Product

Resources

About